Post-Covid-19 Epidemic Era, Drug Discovery Services Industry Development Trend Analysis Report 2023
The global Drug Discovery Services market size in 2022 is 14680.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 15.00% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Drug Discovery Services market include General Electric (U.S.), Eurofins Scientific (U.S.), PPD Inc. (U.S.), Syngene International Limited (India), and Wuxi AppTec (China). The share of the top 3 players in the Drug Discovery Services market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Drug Discovery Services market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Medicinal Chemistry Services accounted for XX% of Drug Discovery Services market in 2022. Biology Services share of XX%.
Neurology accounted for XX% of the Drug Discovery Services market in 2022. Diabetes accounts for XX%.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Drug Discovery Services Market dynamics, structure by identifying and analyzing the market segments and project the global market size.
In addition, the market SWOT analysis, dynamics, trends, technologies, opportunities and challenges analysis are covered in the report.
Further, the report also focuses on the competitive analysis of key players by product, financial position, product portfolio, growth strategies, and regional presence.
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Highlights-Regions
North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Nordic
Latin America
Brazil
Argentina
Mexico
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Player list
General Electric (U.S.)
Eurofins Scientific (U.S.)
PPD Inc. (U.S.)
Syngene International Limited (India)
Wuxi AppTec (China)
Frontage Labs (U.S.)
Galapagos NV (Belgium)
Aurigene Discovery Technologies (India)
Genscript (U.S.)
Domainex (U.K.)
WIL Research Laboratories LLC (U.S.)
Shanghai Medicilon, Inc. (China)
Labcorp Drug Development (U.S.)
Jubilant Biosys Ltd. (India)
Evotec (Germany)
Shanghai ChemPartner (China)
Charles River Laboratories (U.S.)
Merck & Co. Inc. (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
Types list
Medicinal Chemistry Services
Biology Services
Drug Metabolism and Pharmacokinetics
Application list
Neurology
Diabetes
Oncology
Respiratory Diseases
Cardiovascular Diseases
Others
Table of Content
1 Drug Discovery Services Market Introduction and Overview
1.1 Drug Discovery Services Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
2 Players Profiles
2.1 General Electric (U.S.)
2.1.1 General Electric (U.S.) Company Profile
2.1.2 Drug Discovery Services Product Overview
2.1.3 General Electric (U.S.) Drug Discovery Services Market Performance (2018-2023)
2.1.4 General Electric (U.S.) Business Overview
2.2 Eurofins Scientific (U.S.)
2.2.1 Eurofins Scientific (U.S.) Company Profile
2.2.2 Drug Discovery Services Product Overview
2.2.3 Eurofins Scientific (U.S.) Drug Discovery Services Market Performance (2018-2023)
2.2.4 Eurofins Scientific (U.S.) Business Overview
2.3 PPD Inc. (U.S.)
2.3.1 PPD Inc. (U.S.) Company Profile
2.3.2 Drug Discovery Services Product Overview
2.3.3 PPD Inc. (U.S.) Drug Discovery Services Market Performance (2018-2023)
2.3.4 PPD Inc. (U.S.) Business Overview
2.4 Syngene International Limited (India)
2.4.1 Syngene International Limited (India) Company Profile
2.4.2 Drug Discovery Services Product Overview
2.4.3 Syngene International Limited (India) Drug Discovery Services Market Performance (2018-2023)
2.4.4 Syngene International Limited (India) Business Overview
2.5 Wuxi AppTec (China)
2.5.1 Wuxi AppTec (China) Company Profile
2.5.2 Drug Discovery Services Product Overview
2.5.3 Wuxi AppTec (China) Drug Discovery Services Market Performance (2018-2023)
2.5.4 Wuxi AppTec (China) Business Overview
2.6 Frontage Labs (U.S.)
2.6.1 Frontage Labs (U.S.) Company Profile
2.6.2 Drug Discovery Services Product Overview
2.6.3 Frontage Labs (U.S.) Drug Discovery Services Market Performance (2018-2023)
2.6.4 Frontage Labs (U.S.) Business Overview
2.7 Galapagos NV (Belgium)
2.7.1 Galapagos NV (Belgium) Company Profile
2.7.2 Drug Discovery Services Product Overview
2.7.3 Galapagos NV (Belgium) Drug Discovery Services Market Performance (2018-2023)
2.7.4 Galapagos NV (Belgium) Business Overview
2.8 Aurigene Discovery Technologies (India)
2.8.1 Aurigene Discovery Technologies (India) Company Profile
2.8.2 Drug Discovery Services Product Overview
2.8.3 Aurigene Discovery Technologies (India) Drug Discovery Services Market Performance (2018-2023)
2.8.4 Aurigene Discovery Technologies (India) Business Overview
2.9 Genscript (U.S.)
2.9.1 Genscript (U.S.) Company Profile
2.9.2 Drug Discovery Services Product Overview
2.9.3 Genscript (U.S.) Drug Discovery Services Market Performance (2018-2023)
2.9.4 Genscript (U.S.) Business Overview
2.10 Domainex (U.K.)
2.10.1 Domainex (U.K.) Company Profile
2.10.2 Drug Discovery Services Product Overview
2.10.3 Domainex (U.K.) Drug Discovery Services Market Performance (2018-2023)
2.10.4 Domainex (U.K.) Business Overview
2.11 WIL Research Laboratories LLC (U.S.)
2.11.1 WIL Research Laboratories LLC (U.S.) Company Profile
2.11.2 Drug Discovery Services Product Overview
2.11.3 WIL Research Laboratories LLC (U.S.) Drug Discovery Services Market Performance (2018-2023)
2.11.4 WIL Research Laboratories LLC (U.S.) Business Overview
2.12 Shanghai Medicilon, Inc. (China)
2.12.1 Shanghai Medicilon, Inc. (China) Company Profile
2.12.2 Drug Discovery Services Product Overview
2.12.3 Shanghai Medicilon, Inc. (China) Drug Discovery Services Market Performance (2018-2023)
2.12.4 Shanghai Medicilon, Inc. (China) Business Overview
2.13 Labcorp Drug Development (U.S.)
2.13.1 Labcorp Drug Development (U.S.) Company Profile
2.13.2 Drug Discovery Services Product Overview
2.13.3 Labcorp Drug Development (U.S.) Drug Discovery Services Market Performance (2018-2023)
2.13.4 Labcorp Drug Development (U.S.) Business Overview
2.14 Jubilant Biosys Ltd. (India)
2.14.1 Jubilant Biosys Ltd. (India) Company Profile
2.14.2 Drug Discovery Services Product Overview
2.14.3 Jubilant Biosys Ltd. (India) Drug Discovery Services Market Performance (2018-2023)
2.14.4 Jubilant Biosys Ltd. (India) Business Overview
2.15 Evotec (Germany)
2.15.1 Evotec (Germany) Company Profile
2.15.2 Drug Discovery Services Product Overview
2.15.3 Evotec (Germany) Drug Discovery Services Market Performance (2018-2023)
2.15.4 Evotec (Germany) Business Overview
2.16 Shanghai ChemPartner (China)
2.16.1 Shanghai ChemPartner (China) Company Profile
2.16.2 Drug Discovery Services Product Overview
2.16.3 Shanghai ChemPartner (China) Drug Discovery Services Market Performance (2018-2023)
2.16.4 Shanghai ChemPartner (China) Business Overview
2.17 Charles River Laboratories (U.S.)
2.17.1 Charles River Laboratories (U.S.) Company Profile
2.17.2 Drug Discovery Services Product Overview
2.17.3 Charles River Laboratories (U.S.) Drug Discovery Services Market Performance (2018-2023)
2.17.4 Charles River Laboratories (U.S.) Business Overview
2.18 Merck & Co. Inc. (U.S.)
2.18.1 Merck & Co. Inc. (U.S.) Company Profile
2.18.2 Drug Discovery Services Product Overview
2.18.3 Merck & Co. Inc. (U.S.) Drug Discovery Services Market Performance (2018-2023)
2.18.4 Merck & Co. Inc. (U.S.) Business Overview
2.19 Thermo Fisher Scientific Inc. (U.S.)
2.19.1 Thermo Fisher Scientific Inc. (U.S.) Company Profile
2.19.2 Drug Discovery Services Product Overview
2.19.3 Thermo Fisher Scientific Inc. (U.S.) Drug Discovery Services Market Performance (2018-2023)
2.19.4 Thermo Fisher Scientific Inc. (U.S.) Business Overview
3 Global Drug Discovery Services Historical and Forecast Market Analysis by Type
3.1 Global Drug Discovery Services Revenue and Market Share by Type
3.2 Global Drug Discovery Services Revenue Market Forecast by Type (2023-2029)
4 Global Drug Discovery Services Historical and Forecast Market Analysis by Application
4.1 Global Drug Discovery Services Revenue Market Share by Application (2018-2023)
4.2 Drug Discovery Services Revenue Market Forecast by Application (2023-2029)
5 Global Market Growth Trends Analysis
5.1 Global Drug Discovery Services Market Size & Forecast (2018-2029)
5.2 Drug Discovery Services Growth Trends Analysis by Regions
5.2.1 Drug Discovery Services Market Size by Regions: 2018 VS 2023 VS 2029
5.2.2 Drug Discovery Services Historic Market Size by Regions (2018-2023)
5.2.3 Drug Discovery Services Forecasted Market Size by Regions (2023-2029)
5.2.4 North America Drug Discovery Services Market Size & Forecast (2018-2029)
5.2.5 Europe Drug Discovery Services Market Size & Forecast (2018-2029)
5.2.6 China Drug Discovery Services Market Size & Forecast (2018-2029)
5.2.7 Asia-Pacific (Excluding China) Drug Discovery Services Market Size & Forecast (2018-2029)
5.2.8 Latin America Drug Discovery Services Market Size & Forecast (2018-2029)
5.2.9 Middle East & Africa Drug Discovery Services Market Size & Forecast (2018-2029)
6 North America
6.1 North America Drug Discovery Services Revenue by Players
6.2 North America Drug Discovery Services Revenue by Types
6.3 North America Drug Discovery Services Revenue by Applications
6.4 North America Drug Discovery Services Market by Countries
6.4.1 North America Drug Discovery Services Revenue by Countries (2018-2029)
6.5 United States
6.6 Canada
7 China
7.1 China Drug Discovery Services Revenue by Players
7.2 China Drug Discovery Services Revenue by Types
7.3 China Drug Discovery Services Revenue by Applications
7.4 China
8 Asia Pacific (Excluding China)
8.1 Asia Pacific Drug Discovery Services Revenue by Players
8.2 Asia Pacific Drug Discovery Services Revenue by Types
8.3 Asia Pacific Drug Discovery Services Revenue by Applications
8.4 Asia Pacific Drug Discovery Services Market by Countries
8.4.1 Asia Pacific Drug Discovery Services Revenue by Countries (2018-2029)
8.5 Japan
8.6 Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Europe
9.1 Europe Drug Discovery Services Revenue by Players
9.2 Europe Drug Discovery Services Revenue by Types
9.3 Europe Drug Discovery Services Revenue by Applications
9.4 Europe Drug Discovery Services Market by Countries
9.4.1 Europe Drug Discovery Services Revenue by Countries (2018-2029)
9.5 Germany
9.6 France
9.7 UK
9.8 Italy
9.9 Russia
9.10 Nordic
10 Latin America
10.1 Latin America Drug Discovery Services Revenue by Players
10.2 Latin America Drug Discovery Services Revenue by Types
10.3 Latin America Drug Discovery Services Revenue by Applications
10.4 Latin America Drug Discovery Services Market by Countries
10.4.1 Latin America Drug Discovery Services Revenue by Countries (2018-2029)
10.5 Brazil
10.6 Argentina
10.7 Mexico
11 Middle East & Africa
11.1 Middle East & Africa Drug Discovery Services Revenue by Players
11.2 Middle East & Africa Drug Discovery Services Revenue by Types
11.3 Middle East & Africa Drug Discovery Services Revenue by Applications
11.4 Middle East & Africa Drug Discovery Services Market by Countries
11.4.1 Middle East & Africa Drug Discovery Services Revenue by Countries (2018-2029)
11.5 Egypt
11.6 South Africa
11.7 Israel
11.8 Turkey
11.9 GCC Countries
12 Drug Discovery Services Industry Dynamic Analysis
12.1 Drug Discovery Services Market Trends Analysis
12.2 Drug Discovery Services Market Drivers Analysis
12.3 Drug Discovery Services Market Challenges Analysis
12.4 Drug Discovery Services Market Restraints Analysis
12.5 Drug Discovery Services Industry Mergers & Acquisitions
12.6 Drug Discovery Services Industry New Entrants and Expansion Plans
13 Research Findings and Conclusion
List of Tables and Figures
Figure Drug Discovery Services Picture
Table Product Definition of Drug Discovery Services
Table Global Drug Discovery Services Market Size by Type (2023 VS 2029)
Table Global Drug Discovery Services Market Size by Application (2023 VS 2029)
Table General Electric (U.S.) Profile
Table Product Overview
Table General Electric (U.S.) Drug Discovery Services Revenue, Gross and Gross Margin (2018-2023)
Figure General Electric (U.S.) Revenue and Growth Rate
Figure General Electric (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Eurofins Scientific (U.S.) Profile
Table Product Overview
Table Eurofins Scientific (U.S.) Drug Discovery Services Revenue, Gross and Gross Margin (2018-2023)
Figure Eurofins Scientific (U.S.) Revenue and Growth Rate
Figure Eurofins Scientific (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table PPD Inc. (U.S.) Profile
Table Product Overview
Table PPD Inc. (U.S.) Drug Discovery Services Revenue, Gross and Gross Margin (2018-2023)
Figure PPD Inc. (U.S.) Revenue and Growth Rate
Figure PPD Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Syngene International Limited (India) Profile
Table Product Overview
Table Syngene International Limited (India) Drug Discovery Services Revenue, Gross and Gross Margin (2018-2023)
Figure Syngene International Limited (India) Revenue and Growth Rate
Figure Syngene International Limited (India) Revenue Market Share 2017-2022
Table Business Overview
Table Wuxi AppTec (China) Profile
Table Product Overview
Table Wuxi AppTec (China) Drug Discovery Services Revenue, Gross and Gross Margin (2018-2023)
Figure Wuxi AppTec (China) Revenue and Growth Rate
Figure Wuxi AppTec (China) Revenue Market Share 2017-2022
Table Business Overview
Table Frontage Labs (U.S.) Profile
Table Product Overview
Table Frontage Labs (U.S.) Drug Discovery Services Revenue, Gross and Gross Margin (2018-2023)
Figure Frontage Labs (U.S.) Revenue and Growth Rate
Figure Frontage Labs (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Galapagos NV (Belgium) Profile
Table Product Overview
Table Galapagos NV (Belgium) Drug Discovery Services Revenue, Gross and Gross Margin (2018-2023)
Figure Galapagos NV (Belgium) Revenue and Growth Rate
Figure Galapagos NV (Belgium) Revenue Market Share 2017-2022
Table Business Overview
Table Aurigene Discovery Technologies (India) Profile
Table Product Overview
Table Aurigene Discovery Technologies (India) Drug Discovery Services Revenue, Gross and Gross Margin (2018-2023)
Figure Aurigene Discovery Technologies (India) Revenue and Growth Rate
Figure Aurigene Discovery Technologies (India) Revenue Market Share 2017-2022
Table Business Overview
Table Genscript (U.S.) Profile
Table Product Overview
Table Genscript (U.S.) Drug Discovery Services Revenue, Gross and Gross Margin (2018-2023)
Figure Genscript (U.S.) Revenue and Growth Rate
Figure Genscript (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Domainex (U.K.) Profile
Table Product Overview
Table Domainex (U.K.) Drug Discovery Services Revenue, Gross and Gross Margin (2018-2023)
Figure Domainex (U.K.) Revenue and Growth Rate
Figure Domainex (U.K.) Revenue Market Share 2017-2022
Table Business Overview
Table WIL Research Laboratories LLC (U.S.) Profile
Table Product Overview
Table WIL Research Laboratories LLC (U.S.) Drug Discovery Services Revenue, Gross and Gross Margin (2018-2023)
Figure WIL Research Laboratories LLC (U.S.) Revenue and Growth Rate
Figure WIL Research Laboratories LLC (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Shanghai Medicilon, Inc. (China) Profile
Table Product Overview
Table Shanghai Medicilon, Inc. (China) Drug Discovery Services Revenue, Gross and Gross Margin (2018-2023)
Figure Shanghai Medicilon, Inc. (China) Revenue and Growth Rate
Figure Shanghai Medicilon, Inc. (China) Revenue Market Share 2017-2022
Table Business Overview
Table Labcorp Drug Development (U.S.) Profile
Table Product Overview
Table Labcorp Drug Development (U.S.) Drug Discovery Services Revenue, Gross and Gross Margin (2018-2023)
Figure Labcorp Drug Development (U.S.) Revenue and Growth Rate
Figure Labcorp Drug Development (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Jubilant Biosys Ltd. (India) Profile
Table Product Overview
Table Jubilant Biosys Ltd. (India) Drug Discovery Services Revenue, Gross and Gross Margin (2018-2023)
Figure Jubilant Biosys Ltd. (India) Revenue and Growth Rate
Figure Jubilant Biosys Ltd. (India) Revenue Market Share 2017-2022
Table Business Overview
Table Evotec (Germany) Profile
Table Product Overview
Table Evotec (Germany) Drug Discovery Services Revenue, Gross and Gross Margin (2018-2023)
Figure Evotec (Germany) Revenue and Growth Rate
Figure Evotec (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Shanghai ChemPartner (China) Profile
Table Product Overview
Table Shanghai ChemPartner (China) Drug Discovery Services Revenue, Gross and Gross Margin (2018-2023)
Figure Shanghai ChemPartner (China) Revenue and Growth Rate
Figure Shanghai ChemPartner (China) Revenue Market Share 2017-2022
Table Business Overview
Table Charles River Laboratories (U.S.) Profile
Table Product Overview
Table Charles River Laboratories (U.S.) Drug Discovery Services Revenue, Gross and Gross Margin (2018-2023)
Figure Charles River Laboratories (U.S.) Revenue and Growth Rate
Figure Charles River Laboratories (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Merck & Co. Inc. (U.S.) Profile
Table Product Overview
Table Merck & Co. Inc. (U.S.) Drug Discovery Services Revenue, Gross and Gross Margin (2018-2023)
Figure Merck & Co. Inc. (U.S.) Revenue and Growth Rate
Figure Merck & Co. Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Thermo Fisher Scientific Inc. (U.S.) Profile
Table Product Overview
Table Thermo Fisher Scientific Inc. (U.S.) Drug Discovery Services Revenue, Gross and Gross Margin (2018-2023)
Figure Thermo Fisher Scientific Inc. (U.S.) Revenue and Growth Rate
Figure Thermo Fisher Scientific Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Global Drug Discovery Services Revenue and Market Size by Type (2018-2023)
Table Global Drug Discovery Services Revenue and Market Share by Type (2018-2023)
Table Global Drug Discovery Services Revenue Market Size Forecast by Type (2023-2029)
Table Global Drug Discovery Services Revenue Market Share Forecast by Type (2023-2029)
Table Global Drug Discovery Services Revenue Market Size by Application (2018-2023)
Table Global Drug Discovery Services Revenue Market Share by Application (2018-2023)
Table Global Drug Discovery Services Revenue Market Size by Application (2023-2029)
Table Global Drug Discovery Services Revenue Market Share by Application (2023-2029)
Figure Global Drug Discovery Services Revenue Market Size & Forecast (2018-2029)
Table Drug Discovery Services Market Size by Regions: 2018 VS 2023 VS 2029
Table Drug Discovery Services Historic Revenue Market Size by Regions (2018-2023)
Table Drug Discovery Services Historic Revenue Market Share by Regions (2018-2023)
Table Drug Discovery Services Forecasted Revenue Market Size by Regions (2023-2029)
Table Drug Discovery Services Forecasted Revenue Market Share by Regions (2023-2029)
Figure North America Drug Discovery Services Market Size & Forecast (2018-2029)
Figure Europe Drug Discovery Services Market Size & Forecast (2018-2029)
Figure China Drug Discovery Services Market Size & Forecast (2018-2029)
Figure Asia-Pacific (Excluding China) Drug Discovery Services Market Size & Forecast (2018-2029)
Figure Latin America Drug Discovery Services Market Size & Forecast (2018-2029)
Figure Middle East & Africa Drug Discovery Services Market Size & Forecast (2018-2029)
Table North America Drug Discovery Services Revenue Share by Players 2022
Table North America Drug Discovery Services Revenue by Types (2018-2023)
Table North America Drug Discovery Services Revenue Market Share by Types (2018-2023)
Table North America Drug Discovery Services Revenue by Applications (2018-2023)
Table North America Drug Discovery Services Revenue Market Share by Applications (2018-2023)
Table North America Drug Discovery Services Revenue by Countries (2018-2029)
Table North America Drug Discovery Services Revenue Market Share by Countries (2018-2029)
Figure United States Drug Discovery Services Revenue and Growth (2018-2029)
Figure Canada Drug Discovery Services Revenue and Growth (2018-2029)
Table China Drug Discovery Services Revenue Share by Players 2022
Table China Drug Discovery Services Revenue by Types (2018-2023)
Table China Drug Discovery Services Revenue Market Share by Types (2018-2023)
Table China Drug Discovery Services Revenue by Applications (2018-2023)
Table China Drug Discovery Services Revenue Market Share by Applications (2018-2023)
Figure China Drug Discovery Services Revenue and Growth (2018-2029)
Table Asia Pacific Drug Discovery Services Revenue Share by Players 2022
Table Asia Pacific Drug Discovery Services Revenue by Types (2018-2023)
Table Asia Pacific Drug Discovery Services Revenue Market Share by Types (2018-2023)
Table Asia Pacific Drug Discovery Services Revenue by Applications (2018-2023)
Table Asia Pacific Drug Discovery Services Revenue Market Share by Applications (2018-2023)
Table Asia-Pacific Drug Discovery Services Revenue by Countries (2018-2029)
Table Asia-Pacific Drug Discovery Services Revenue Market Share by Countries (2018-2029)
Figure Japan Drug Discovery Services Revenue and Growth (2018-2029)
Figure Korea Drug Discovery Services Revenue and Growth (2018-2029)
Figure Southeast Asia Drug Discovery Services Revenue and Growth (2018-2029)
Figure India Drug Discovery Services Revenue and Growth (2018-2029)
Figure Australia Drug Discovery Services Revenue and Growth (2018-2029)
Table Europe Drug Discovery Services Revenue Share by Players 2022
Table Europe Drug Discovery Services Revenue by Types (2018-2023)
Table Europe Drug Discovery Services Revenue Market Share by Types (2018-2023)
Table Europe Drug Discovery Services Revenue by Applications (2018-2023)
Table Europe Drug Discovery Services Revenue Market Share by Applications (2018-2023)
Table Europe Drug Discovery Services Revenue by Countries (2018-2029)
Table Europe Drug Discovery Services Revenue Market Share by Countries (2018-2029)
Figure Germany Drug Discovery Services Revenue and Growth (2018-2029)
Figure France Drug Discovery Services Revenue and Growth (2018-2029)
Figure UK Drug Discovery Services Revenue and Growth (2018-2029)
Figure Italy Drug Discovery Services Revenue and Growth (2018-2029)
Figure Russia Drug Discovery Services Revenue and Growth (2018-2029)
Figure Nordic Drug Discovery Services Revenue and Growth (2018-2029)
Table Latin America Drug Discovery Services Revenue Share by Players 2022
Table Latin America Drug Discovery Services Revenue by Types (2018-2023)
Table Latin America Drug Discovery Services Revenue Market Share by Types (2018-2023)
Table Latin America Drug Discovery Services Revenue by Applications (2018-2023)
Table Latin America Drug Discovery Services Revenue Market Share by Applications (2018-2023)
Table Latin America Drug Discovery Services Revenue by Countries (2018-2029)
Table Latin America Drug Discovery Services Revenue Market Share by Countries (2018-2029)
Figure Brazil Drug Discovery Services Revenue and Growth (2018-2029)
Figure Argentina Drug Discovery Services Revenue and Growth (2018-2029)
Figure Mexico Drug Discovery Services Revenue and Growth (2018-2029)
Table Latin America Drug Discovery Services Revenue Share by Players 2022
Table Middle East & Africa Drug Discovery Services Revenue by Types (2018-2023)
Table Middle East & Africa Drug Discovery Services Revenue Market Share by Types (2018-2023)
Table Middle East & Africa Drug Discovery Services Revenue by Applications (2018-2023)
Table Middle East & Africa Drug Discovery Services Revenue Market Share by Applications (2018-2023)
Table Middle East & Africa Drug Discovery Services Revenue by Countries (2018-2029)
Table Middle East & Africa Drug Discovery Services Revenue Market Share by Countries (2018-2029)
Figure Egypt Drug Discovery Services Revenue and Growth (2018-2029)
Figure South Africa Drug Discovery Services Revenue and Growth (2018-2029)
Figure Israel Drug Discovery Services Revenue and Growth (2018-2029)
Figure Turkey Drug Discovery Services Revenue and Growth (2018-2029)
Figure GCC Countries Drug Discovery Services Revenue and Growth (2018-2029)
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Market Mergers & Acquisitions
Table Market New Entrants and Expansion Plans
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|